| Symbol |
Name |
|
AAK1
|
AP2 associated kinase 1
|
|
ABL1
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
|
ACACA
|
acetyl-CoA carboxylase alpha
|
|
ACAP1
|
ArfGAP with coiled-coil, ankyrin repeat and PH domains 1
|
|
ADAM17
|
ADAM metallopeptidase domain 17
|
|
ADD1
|
adducin 1 (alpha)
|
|
ADRA2A
|
adrenoceptor alpha 2A
|
|
ADRBK1
|
adrenergic, beta, receptor kinase 1
|
|
AGAP2
|
ArfGAP with GTPase domain, ankyrin repeat and PH domain 2
|
|
AGO2
|
argonaute RISC catalytic component 2
|
|
AGTR1
|
angiotensin II receptor, type 1
|
|
AICDA
|
activation-induced cytidine deaminase
|
|
AJUBA
|
ajuba LIM protein
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
AKT1S1
|
AKT1 substrate 1 (proline-rich)
|
|
AKT2
|
v-akt murine thymoma viral oncogene homolog 2
|
|
AKTIP
|
AKT interacting protein
|
|
ALB
|
albumin
|
|
ALK
|
anaplastic lymphoma receptor tyrosine kinase
|
|
ALYREF
|
Aly/REF export factor
|
|
ANKRD17
|
ankyrin repeat domain 17
|
|
AP2B1
|
adaptor-related protein complex 2, beta 1 subunit
|
|
APBB2
|
amyloid beta (A4) precursor protein-binding, family B, member 2
|
|
APPL1
|
adaptor protein, phosphotyrosine interaction, PH domain and leucine zipper containing 1
|
|
ARFIP2
|
ADP-ribosylation factor interacting protein 2
|
|
ARHGAP15
|
Rho GTPase activating protein 15
|
|
ARHGAP35
|
Rho GTPase activating protein 35
|
|
ARHGDIA
|
Rho GDP dissociation inhibitor (GDI) alpha
|
|
ARHGEF2
|
Rho/Rac guanine nucleotide exchange factor (GEF) 2
|
|
ARHGEF7
|
Rho guanine nucleotide exchange factor (GEF) 7
|
|
ARPP21
|
cAMP-regulated phosphoprotein, 21kDa
|
|
ASAP3
|
ArfGAP with SH3 domain, ankyrin repeat and PH domain 3
|
|
ATF2
|
activating transcription factor 2
|
|
ATG5
|
autophagy related 5
|
|
ATM
|
ATM serine/threonine kinase
|
|
ATRIP
|
ATR interacting protein
|
|
AVEN
|
apoptosis, caspase activation inhibitor
|
|
AXL
|
AXL receptor tyrosine kinase
|
|
BAD
|
BCL2-associated agonist of cell death
|
|
BAIAP2
|
BAI1-associated protein 2
|
|
BBC3
|
BCL2 binding component 3
|
|
BCAR1
|
breast cancer anti-estrogen resistance 1
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCL2L11
|
BCL2-like 11 (apoptosis facilitator)
|
|
BID
|
BH3 interacting domain death agonist
|
|
BIRC5
|
baculoviral IAP repeat containing 5
|
|
BLNK
|
B-cell linker
|
|
BMX
|
BMX non-receptor tyrosine kinase
|
|
BPGM
|
2,3-bisphosphoglycerate mutase
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
BRSK1
|
BR serine/threonine kinase 1
|
|
BRSK2
|
BR serine/threonine kinase 2
|
|
BTK
|
Bruton agammaglobulinemia tyrosine kinase
|
|
BUB1B
|
BUB1 mitotic checkpoint serine/threonine kinase B
|
|
CACNA1H
|
calcium channel, voltage-dependent, T type, alpha 1H subunit
|
|
CAD
|
carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase
|
|
CALD1
|
caldesmon 1
|
|
CALM1
|
calmodulin 1 (phosphorylase kinase, delta)
|
|
CAMK2A
|
calcium/calmodulin-dependent protein kinase II alpha
|
|
CASP6
|
caspase 6, apoptosis-related cysteine peptidase
|
|
CASP8
|
caspase 8, apoptosis-related cysteine peptidase
|
|
CASP9
|
caspase 9, apoptosis-related cysteine peptidase
|
|
CAT
|
catalase
|
|
CAV1
|
caveolin 1, caveolae protein, 22kDa
|
|
CCR5
|
chemokine (C-C motif) receptor 5 (gene/pseudogene)
|
|
CD22
|
CD22 molecule
|
|
CD247
|
CD247 molecule
|
|
CD3E
|
CD3e molecule, epsilon (CD3-TCR complex)
|
|
CD79A
|
CD79a molecule, immunoglobulin-associated alpha
|
|
CD84
|
CD84 molecule
|
|
CDC25C
|
cell division cycle 25C
|
|
CDK1
|
cyclin-dependent kinase 1
|
|
CDK5
|
cyclin-dependent kinase 5
|
|
CDKN1B
|
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
|
|
CEBPB
|
CCAAT/enhancer binding protein (C/EBP), beta
|
|
CFL1
|
cofilin 1 (non-muscle)
|
|
CHEK1
|
checkpoint kinase 1
|
|
CHEK2
|
checkpoint kinase 2
|
|
CHUK
|
conserved helix-loop-helix ubiquitous kinase
|
|
CLEC1B
|
C-type lectin domain family 1, member B
|
|
CLTC
|
clathrin, heavy chain (Hc)
|
|
COX2
|
|
|
COX5A
|
cytochrome c oxidase subunit Va
|
|
COX5B
|
cytochrome c oxidase subunit Vb
|
|
COX7C
|
cytochrome c oxidase subunit VIIc
|
|
CREB1
|
cAMP responsive element binding protein 1
|
|
CREM
|
cAMP responsive element modulator
|
|
CRHR1
|
corticotropin releasing hormone receptor 1
|
|
CRK
|
v-crk avian sarcoma virus CT10 oncogene homolog
|
|
CRKL
|
v-crk avian sarcoma virus CT10 oncogene homolog-like
|
|
CRMP1
|
collapsin response mediator protein 1
|
|
CROCC
|
ciliary rootlet coiled-coil, rootletin
|
|
CRYAB
|
crystallin, alpha B
|
|
CSF1R
|
colony stimulating factor 1 receptor
|
|
CSF2RB
|
colony stimulating factor 2 receptor, beta, low-affinity (granulocyte-macrophage)
|
|
CTLA4
|
cytotoxic T-lymphocyte-associated protein 4
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CTTN
|
cortactin
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
|
DAB1
|
Dab, reelin signal transducer, homolog 1 (Drosophila)
|
|
DAB2
|
Dab, mitogen-responsive phosphoprotein, homolog 2 (Drosophila)
|
|
DAPK1
|
death-associated protein kinase 1
|
|
DAPP1
|
dual adaptor of phosphotyrosine and 3-phosphoinositides
|
|
DCLRE1C
|
DNA cross-link repair 1C
|
|
DCP1A
|
decapping mRNA 1A
|
|
DCTN1
|
dynactin 1
|
|
DDX5
|
DEAD (Asp-Glu-Ala-Asp) box helicase 5
|
|
DIAPH1
|
diaphanous-related formin 1
|
|
DNM1L
|
dynamin 1-like
|
|
DNM2
|
dynamin 2
|
|
DOK1
|
docking protein 1, 62kDa (downstream of tyrosine kinase 1)
|
|
DPYSL2
|
dihydropyrimidinase-like 2
|
|
DSTN
|
destrin (actin depolymerizing factor)
|
|
DVL2
|
dishevelled segment polarity protein 2
|
|
E2F3
|
E2F transcription factor 3
|
|
EEA1
|
early endosome antigen 1
|
|
EFNB2
|
ephrin-B2
|
|
EGFR
|
epidermal growth factor receptor
|
|
EIF2S1
|
eukaryotic translation initiation factor 2, subunit 1 alpha, 35kDa
|
|
EIF2S3
|
eukaryotic translation initiation factor 2, subunit 3 gamma, 52kDa
|
|
EIF3F
|
eukaryotic translation initiation factor 3, subunit F
|
|
EIF4E
|
eukaryotic translation initiation factor 4E
|
|
EIF4EBP1
|
eukaryotic translation initiation factor 4E binding protein 1
|
|
ELK1
|
ELK1, member of ETS oncogene family
|
|
EMD
|
emerin
|
|
EPOR
|
erythropoietin receptor
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ERBB3
|
erb-b2 receptor tyrosine kinase 3
|
|
ERF
|
Ets2 repressor factor
|
|
ETS1
|
v-ets avian erythroblastosis virus E26 oncogene homolog 1
|
|
ETV1
|
ets variant 1
|
|
EZR
|
ezrin
|
|
FADD
|
Fas (TNFRSF6)-associated via death domain
|
|
FCRL6
|
Fc receptor-like 6
|
|
FGF2
|
fibroblast growth factor 2 (basic)
|
|
FHIT
|
fragile histidine triad
|
|
FLT1
|
fms-related tyrosine kinase 1
|
|
FLT3
|
fms-related tyrosine kinase 3
|
|
FMR1
|
fragile X mental retardation 1
|
|
FOXO1
|
forkhead box O1
|
|
FOXO3
|
forkhead box O3
|
|
FOXO4
|
forkhead box O4
|
|
FXR1
|
fragile X mental retardation, autosomal homolog 1
|
|
G3BP1
|
GTPase activating protein (SH3 domain) binding protein 1
|
|
GAB2
|
GRB2-associated binding protein 2
|
|
GABBR1
|
gamma-aminobutyric acid (GABA) B receptor, 1
|
|
GABRA1
|
gamma-aminobutyric acid (GABA) A receptor, alpha 1
|
|
GAP43
|
growth associated protein 43
|
|
GAPDH
|
glyceraldehyde-3-phosphate dehydrogenase
|
|
GATA4
|
GATA binding protein 4
|
|
GCH1
|
GTP cyclohydrolase 1
|
|
GIT1
|
G protein-coupled receptor kinase interacting ArfGAP 1
|
|
GJA1
|
gap junction protein, alpha 1, 43kDa
|
|
GLI1
|
GLI family zinc finger 1
|
|
GNA15
|
guanine nucleotide binding protein (G protein), alpha 15 (Gq class)
|
|
GNAQ
|
guanine nucleotide binding protein (G protein), q polypeptide
|
|
GNAZ
|
guanine nucleotide binding protein (G protein), alpha z polypeptide
|
|
GRIA1
|
glutamate receptor, ionotropic, AMPA 1
|
|
GRIN1
|
glutamate receptor, ionotropic, N-methyl D-aspartate 1
|
|
GSK3A
|
glycogen synthase kinase 3 alpha
|
|
GSK3B
|
glycogen synthase kinase 3 beta
|
|
H2AFX
|
H2A histone family, member X
|
|
HCLS1
|
hematopoietic cell-specific Lyn substrate 1
|
|
HCN4
|
hyperpolarization activated cyclic nucleotide gated potassium channel 4
|
|
HIST1H3A
|
histone cluster 1, H3a
|
|
HSPB1
|
heat shock 27kDa protein 1
|
|
HTR2A
|
5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled
|
|
IER3
|
immediate early response 3
|
|
IFI16
|
interferon, gamma-inducible protein 16
|
|
IGF1R
|
insulin-like growth factor 1 receptor
|
|
IKBKB
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta
|
|
IL4R
|
interleukin 4 receptor
|
|
IQGAP1
|
IQ motif containing GTPase activating protein 1
|
|
IQGAP2
|
IQ motif containing GTPase activating protein 2
|
|
IRF3
|
interferon regulatory factor 3
|
|
IRF5
|
interferon regulatory factor 5
|
|
IRS1
|
insulin receptor substrate 1
|
|
IRS2
|
insulin receptor substrate 2
|
|
ITGB4
|
integrin, beta 4
|
|
JAK1
|
Janus kinase 1
|
|
JAK2
|
Janus kinase 2
|
|
JUN
|
jun proto-oncogene
|
|
KALRN
|
kalirin, RhoGEF kinase
|
|
KCNJ11
|
potassium channel, inwardly rectifying subfamily J, member 11
|
|
KCNK2
|
potassium channel, two pore domain subfamily K, member 2
|
|
KDR
|
kinase insert domain receptor
|
|
KMT2A
|
lysine (K)-specific methyltransferase 2A
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
KRT8
|
keratin 8, type II
|
|
KSR1
|
kinase suppressor of ras 1
|
|
LAT
|
linker for activation of T cells
|
|
LCK
|
LCK proto-oncogene, Src family tyrosine kinase
|
|
LHCGR
|
luteinizing hormone/choriogonadotropin receptor
|
|
LIMK1
|
LIM domain kinase 1
|
|
LIMK2
|
LIM domain kinase 2
|
|
LPCAT1
|
lysophosphatidylcholine acyltransferase 1
|
|
LRRK2
|
leucine-rich repeat kinase 2
|
|
MAFA
|
v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog A
|
|
MAP2K1
|
mitogen-activated protein kinase kinase 1
|
|
MAP2K2
|
mitogen-activated protein kinase kinase 2
|
|
MAP3K5
|
mitogen-activated protein kinase kinase kinase 5
|
|
MAP3K8
|
mitogen-activated protein kinase kinase kinase 8
|
|
MAP4K1
|
mitogen-activated protein kinase kinase kinase kinase 1
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK14
|
mitogen-activated protein kinase 14
|
|
MAPK15
|
mitogen-activated protein kinase 15
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MAPK8
|
mitogen-activated protein kinase 8
|
|
MAPKAPK2
|
mitogen-activated protein kinase-activated protein kinase 2
|
|
MAPKAPK3
|
mitogen-activated protein kinase-activated protein kinase 3
|
|
MAPT
|
microtubule-associated protein tau
|
|
MARCKS
|
myristoylated alanine-rich protein kinase C substrate
|
|
MARK2
|
MAP/microtubule affinity-regulating kinase 2
|
|
MCM2
|
minichromosome maintenance complex component 2
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
MED1
|
mediator complex subunit 1
|
|
MEF2C
|
myocyte enhancer factor 2C
|
|
MEF2D
|
myocyte enhancer factor 2D
|
|
MET
|
MET proto-oncogene, receptor tyrosine kinase
|
|
MSN
|
moesin
|
|
MSX2
|
msh homeobox 2
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
MUC1
|
mucin 1, cell surface associated
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
MYH9
|
myosin, heavy chain 9, non-muscle
|
|
MYL12B
|
myosin, light chain 12B, regulatory
|
|
MYL9
|
myosin, light chain 9, regulatory
|
|
NBN
|
nibrin
|
|
NCBP1
|
nuclear cap binding protein subunit 1, 80kDa
|
|
NDRG1
|
N-myc downstream regulated 1
|
|
NEDD4L
|
neural precursor cell expressed, developmentally down-regulated 4-like, E3 ubiquitin protein ligase
|
|
NET1
|
neuroepithelial cell transforming 1
|
|
NF2
|
neurofibromin 2 (merlin)
|
|
NFATC1
|
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1
|
|
NFE2
|
nuclear factor, erythroid 2
|
|
NFKBIA
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha
|
|
NKX3-1
|
NK3 homeobox 1
|
|
NOS2
|
nitric oxide synthase 2, inducible
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
|
NPHS1
|
nephrosis 1, congenital, Finnish type (nephrin)
|
|
NPM1
|
nucleophosmin (nucleolar phosphoprotein B23, numatrin)
|
|
NR2C1
|
nuclear receptor subfamily 2, group C, member 1
|
|
NR3C1
|
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)
|
|
NTRK1
|
neurotrophic tyrosine kinase, receptor, type 1
|
|
NTRK2
|
neurotrophic tyrosine kinase, receptor, type 2
|
|
NYAP2
|
neuronal tyrosine-phosphorylated phosphoinositide-3-kinase adaptor 2
|
|
OPRK1
|
opioid receptor, kappa 1
|
|
OPRM1
|
opioid receptor, mu 1
|
|
PA2G4
|
proliferation-associated 2G4, 38kDa
|
|
PAK1
|
p21 protein (Cdc42/Rac)-activated kinase 1
|
|
PAK2
|
p21 protein (Cdc42/Rac)-activated kinase 2
|
|
PAK3
|
p21 protein (Cdc42/Rac)-activated kinase 3
|
|
PAK4
|
p21 protein (Cdc42/Rac)-activated kinase 4
|
|
PANX2
|
pannexin 2
|
|
PARD3
|
par-3 family cell polarity regulator
|
|
PARVA
|
parvin, alpha
|
|
PDC
|
phosducin
|
|
PDE3B
|
phosphodiesterase 3B, cGMP-inhibited
|
|
PDE6G
|
phosphodiesterase 6G, cGMP-specific, rod, gamma
|
|
PDE6H
|
phosphodiesterase 6H, cGMP-specific, cone, gamma
|
|
PDGFRA
|
platelet-derived growth factor receptor, alpha polypeptide
|
|
PDGFRB
|
platelet-derived growth factor receptor, beta polypeptide
|
|
PDPK1
|
3-phosphoinositide dependent protein kinase 1
|
|
PDX1
|
pancreatic and duodenal homeobox 1
|
|
PDZD11
|
PDZ domain containing 11
|
|
PEA15
|
phosphoprotein enriched in astrocytes 15
|
|
PI4KB
|
phosphatidylinositol 4-kinase, catalytic, beta
|
|
PIK3AP1
|
phosphoinositide-3-kinase adaptor protein 1
|
|
PIK3R1
|
phosphoinositide-3-kinase, regulatory subunit 1 (alpha)
|
|
PIKFYVE
|
phosphoinositide kinase, FYVE finger containing
|
|
PJA2
|
praja ring finger 2, E3 ubiquitin protein ligase
|
|
PKLR
|
pyruvate kinase, liver and RBC
|
|
PKM
|
pyruvate kinase, muscle
|
|
PKN1
|
protein kinase N1
|
|
PLA2G4A
|
phospholipase A2, group IVA (cytosolic, calcium-dependent)
|
|
PLCG1
|
phospholipase C, gamma 1
|
|
PLEKHG5
|
pleckstrin homology domain containing, family G (with RhoGef domain) member 5
|
|
PLK1
|
polo-like kinase 1
|
|
PLN
|
phospholamban
|
|
PLSCR3
|
phospholipid scramblase 3
|
|
PPARA
|
peroxisome proliferator-activated receptor alpha
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
|
PPP1R12A
|
protein phosphatase 1, regulatory subunit 12A
|
|
PPP1R14A
|
protein phosphatase 1, regulatory (inhibitor) subunit 14A
|
|
PPP1R1B
|
protein phosphatase 1, regulatory (inhibitor) subunit 1B
|
|
PPP2CA
|
protein phosphatase 2, catalytic subunit, alpha isozyme
|
|
PPP2R5D
|
protein phosphatase 2, regulatory subunit B', delta
|
|
PRDX1
|
peroxiredoxin 1
|
|
PRKAA1
|
protein kinase, AMP-activated, alpha 1 catalytic subunit
|
|
PRKAA2
|
protein kinase, AMP-activated, alpha 2 catalytic subunit
|
|
PRKCA
|
protein kinase C, alpha
|
|
PRKCB
|
protein kinase C, beta
|
|
PRKCD
|
protein kinase C, delta
|
|
PRKCE
|
protein kinase C, epsilon
|
|
PRKCQ
|
protein kinase C, theta
|
|
PRKD1
|
protein kinase D1
|
|
PRLR
|
prolactin receptor
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTGIR
|
prostaglandin I2 (prostacyclin) receptor (IP)
|
|
PTK2
|
protein tyrosine kinase 2
|
|
PTK2B
|
protein tyrosine kinase 2 beta
|
|
PTPN1
|
protein tyrosine phosphatase, non-receptor type 1
|
|
PTPN5
|
protein tyrosine phosphatase, non-receptor type 5 (striatum-enriched)
|
|
PTPRA
|
protein tyrosine phosphatase, receptor type, A
|
|
PTPRE
|
protein tyrosine phosphatase, receptor type, E
|
|
PTTG1
|
pituitary tumor-transforming 1
|
|
PXN
|
paxillin
|
|
PYGM
|
phosphorylase, glycogen, muscle
|
|
RAB11FIP2
|
RAB11 family interacting protein 2 (class I)
|
|
RAB11FIP3
|
RAB11 family interacting protein 3 (class II)
|
|
RAB11FIP5
|
RAB11 family interacting protein 5 (class I)
|
|
RAB24
|
RAB24, member RAS oncogene family
|
|
RAB3IP
|
RAB3A interacting protein
|
|
RABEP1
|
rabaptin, RAB GTPase binding effector protein 1
|
|
RAD9A
|
RAD9 homolog A (S. pombe)
|
|
RAF1
|
Raf-1 proto-oncogene, serine/threonine kinase
|
|
RALA
|
v-ral simian leukemia viral oncogene homolog A (ras related)
|
|
RAP1B
|
RAP1B, member of RAS oncogene family
|
|
RAPGEF1
|
Rap guanine nucleotide exchange factor (GEF) 1
|
|
RAPGEF2
|
Rap guanine nucleotide exchange factor (GEF) 2
|
|
RAPH1
|
Ras association (RalGDS/AF-6) and pleckstrin homology domains 1
|
|
RASSF1
|
Ras association (RalGDS/AF-6) domain family member 1
|
|
RB1
|
retinoblastoma 1
|
|
RBSN
|
rabenosyn, RAB effector
|
|
RDX
|
radixin
|
|
RELA
|
v-rel avian reticuloendotheliosis viral oncogene homolog A
|
|
RET
|
ret proto-oncogene
|
|
RGS14
|
regulator of G-protein signaling 14
|
|
RGS16
|
regulator of G-protein signaling 16
|
|
RHOA
|
ras homolog family member A
|
|
RHOU
|
ras homolog family member U
|
|
RIMS1
|
regulating synaptic membrane exocytosis 1
|
|
RIN1
|
Ras and Rab interactor 1
|
|
ROCK2
|
Rho-associated, coiled-coil containing protein kinase 2
|
|
RPH3A
|
rabphilin 3A
|
|
RPS6
|
ribosomal protein S6
|
|
RPS6KA1
|
ribosomal protein S6 kinase, 90kDa, polypeptide 1
|
|
RPS6KA3
|
ribosomal protein S6 kinase, 90kDa, polypeptide 3
|
|
RPS6KA5
|
ribosomal protein S6 kinase, 90kDa, polypeptide 5
|
|
RPS6KB1
|
ribosomal protein S6 kinase, 70kDa, polypeptide 1
|
|
RPS6KB2
|
ribosomal protein S6 kinase, 70kDa, polypeptide 2
|
|
RPTOR
|
regulatory associated protein of MTOR, complex 1
|
|
RRAS
|
related RAS viral (r-ras) oncogene homolog
|
|
RRM2
|
ribonucleotide reductase M2
|
|
RRN3
|
RRN3 RNA polymerase I transcription factor homolog (S. cerevisiae)
|
|
RTKN
|
rhotekin
|
|
RUFY1
|
RUN and FYVE domain containing 1
|
|
RYR1
|
ryanodine receptor 1 (skeletal)
|
|
RYR2
|
ryanodine receptor 2 (cardiac)
|
|
SATB1
|
SATB homeobox 1
|
|
SETMAR
|
SET domain and mariner transposase fusion gene
|
|
SH2B3
|
SH2B adaptor protein 3
|
|
SH3GL2
|
SH3-domain GRB2-like 2
|
|
SHC1
|
SHC (Src homology 2 domain containing) transforming protein 1
|
|
SIT1
|
signaling threshold regulating transmembrane adaptor 1
|
|
SLC12A3
|
solute carrier family 12 (sodium/chloride transporter), member 3
|
|
SMAD1
|
SMAD family member 1
|
|
SMAD2
|
SMAD family member 2
|
|
SMAD3
|
SMAD family member 3
|
|
SMAD4
|
SMAD family member 4
|
|
SMC1A
|
structural maintenance of chromosomes 1A
|
|
SNAP25
|
synaptosomal-associated protein, 25kDa
|
|
SP1
|
Sp1 transcription factor
|
|
SRC
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
|
SRCIN1
|
SRC kinase signaling inhibitor 1
|
|
STAT1
|
signal transducer and activator of transcription 1, 91kDa
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STAT4
|
signal transducer and activator of transcription 4
|
|
STAT5A
|
signal transducer and activator of transcription 5A
|
|
STAT5B
|
signal transducer and activator of transcription 5B
|
|
STAT6
|
signal transducer and activator of transcription 6, interleukin-4 induced
|
|
STK11
|
serine/threonine kinase 11
|
|
STK3
|
serine/threonine kinase 3
|
|
STK38
|
serine/threonine kinase 38
|
|
STK4
|
serine/threonine kinase 4
|
|
STMN1
|
stathmin 1
|
|
STMN2
|
stathmin 2
|
|
STT3A
|
STT3A, subunit of the oligosaccharyltransferase complex (catalytic)
|
|
SYK
|
spleen tyrosine kinase
|
|
SYN1
|
synapsin I
|
|
SYN3
|
synapsin III
|
|
TBC1D4
|
TBC1 domain family, member 4
|
|
TBX21
|
T-box 21
|
|
TIAM1
|
T-cell lymphoma invasion and metastasis 1
|
|
TIAM2
|
T-cell lymphoma invasion and metastasis 2
|
|
TIGIT
|
T cell immunoreceptor with Ig and ITIM domains
|
|
TNNI3
|
troponin I type 3 (cardiac)
|
|
TNNT2
|
troponin T type 2 (cardiac)
|
|
TP53
|
tumor protein p53
|
|
TRIM28
|
tripartite motif containing 28
|
|
TSC1
|
tuberous sclerosis 1
|
|
TSC2
|
tuberous sclerosis 2
|
|
TWIST1
|
twist family bHLH transcription factor 1
|
|
USO1
|
USO1 vesicle transport factor
|
|
VASP
|
vasodilator-stimulated phosphoprotein
|
|
VAV1
|
vav 1 guanine nucleotide exchange factor
|
|
VIM
|
vimentin
|
|
WAS
|
Wiskott-Aldrich syndrome
|
|
WASF1
|
WAS protein family, member 1
|
|
WASL
|
Wiskott-Aldrich syndrome-like
|
|
WWOX
|
WW domain containing oxidoreductase
|
|
XPO1
|
exportin 1
|
|
YAP1
|
Yes-associated protein 1
|
|
ZAP70
|
zeta-chain (TCR) associated protein kinase 70kDa
|
|
ZFP36
|
ZFP36 ring finger protein
|
